According to the latest report by IMARC Group, “Global Herpes Simplex Virus Treatment Market Trends, Share, Growth, Industry Size, Opportunity and Forecast 2022-2027“, the global herpes simplex virus treatment market reached a value of US$ 2.32 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.25 Billion by 2027 exhibiting a CAGR of 5.50% during 2022-2027.
Herpes simplex virus (HSV) represents a contagious infection that can spread via semen, saliva, and vaginal secretions and cause painful blisters or ulcers. It is usually diagnosed by physical examinations, fluid sampling, blood tests, etc. Presently, antiviral medications, such as acyclovir, famciclovir, valacyclovir, etc., are the most effective treatment options available for patients. These medications are administered through oral or intravenous (IV) routes to help reduce the frequency and severity of outbreaks, relieve symptoms, prevent the transmission of the virus, etc.
|Base Year: 2021|
|Forecast Year: 2022-2027|
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Herpes Simplex Virus Treatment Market Trends and Drivers:
The rising prevalence of hospital-acquired infections and low immunity disorders, on account of the sudden outbreak of the COVID-19 pandemic across the globe, is primarily driving the herpes simplex virus treatment market. Additionally, HSV increases the risk of transmitting and acquiring human immunodeficiency virus (HIV) disease and can lead to severe complications, including keratitis and encephalitis in individuals with long-term or chronic illnesses, which is further catalyzing the market growth.
Besides this, the growing birth rates across developing countries are acting as significant growth-inducing factors. Moreover, the inflating investments in R&D activities aimed at developing low concentration acyclovir medications to expand the treatment options for genital and orolabial herpes are also positively influencing the global market.
Apart from this, the introduction of antiviral creams or ointments that can relieve itching, burning, and tingling sensations caused by HSV is anticipated to fuel the herpes simplex virus treatment market over the forecasted period.
Global Herpes Simplex Virus Treatment Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
The report has segmented the market on the basis of region, type, drug type, route of administration and distribution channel.
Breakup by Type:
- Herpes Simples Virus-1 Infection
- Herpes Simplex Virus-2 Infection
Breakup by Drug Type:
The Breakup by Route of Administration:
Breakup by Distribution Channel:
- Hospital Pharmacy
- Drug Stores
- Retail Stores
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Continue Reading: Cyber Situational Awareness Market Trends, Forecast 2022-27
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800